Scottish cell signalling unit forging links with industry
This article was originally published in Scrip
The Scottish Institute for Cell Signalling (SCILLS) at the University of Dundee says its new unit for research into ubiquitylation, the body's mechanism for controlling cell activity, is attracting strong interest from the pharmaceutical industry. The research is expected to lead to the development of new drugs for conditions such as cancer and inflammatory diseases.
You may also be interested in...
In addition to our daily in-depth coverage of key events relating to the COVID-19 pandemic, we’re bringing you a periodic round-up of other developments. This edition covers Europe and other countries.
The US company is bringing extra supplies of lopinavir/ritonavir into France but stresses that the combination treatment is not authorized for treating patients with the coronavirus.
As part of its efforts to preserve patient access to medicines amid the COVID-19 pandemic, Russia is planning to cap drug prices if increases of more than 30% are detected. It will also allow online sales of non-prescription drugs and may also tighten the rules on fake and substandard products.